Your browser doesn't support javascript.
loading
Comparative efficacy and safety of PD-1/PD-L1 Inhibitors versus platinum-based chemotherapy for the first-line treatment of advanced non-small cell lung cancer: a meta analysis of randomized controlled trials.
Li, Zhi-Qiang; Yan, Hai-Cui; Gu, Jing-Jing; Yang, Yong-Liang; Zhang, Ming-Kui; Fang, Xin-Jian.
Affiliation
  • Li ZQ; The Second People's Hospital of Lianyungang, The Affiliated Hospital of Bengbu Medical College, Lianyungang, Jiangsu, China.
  • Yan HC; Center of Clinical Oncology, The Second People's Hospital, Lianyungang, Jiangsu, China.
  • Gu JJ; The Second People's Hospital of Lianyungang, The Affiliated Hospital of Bengbu Medical College, Lianyungang, Jiangsu, China.
  • Yang YL; The Second People's Hospital of Lianyungang, The Affiliated Hospital of Bengbu Medical College, Lianyungang, Jiangsu, China.
  • Zhang MK; Department of Oncology, The People's Hospital of Ganyu District, Lianyungang, Jiangsu, China. Electronic address: XinLing9453@163.com.
  • Fang XJ; The Second People's Hospital of Lianyungang, The Affiliated Hospital of Bengbu Medical College, Lianyungang, Jiangsu, China. Electronic address: lygfxj@126.com.
Pharmacol Res ; 160: 105194, 2020 10.
Article in En | MEDLINE | ID: mdl-32937178

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Platinum Compounds / Carcinoma, Non-Small-Cell Lung / B7-H1 Antigen / Programmed Cell Death 1 Receptor / Lung Neoplasms / Antineoplastic Agents Type of study: Clinical_trials / Systematic_reviews Limits: Humans Language: En Journal: Pharmacol Res Journal subject: FARMACOLOGIA Year: 2020 Type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Platinum Compounds / Carcinoma, Non-Small-Cell Lung / B7-H1 Antigen / Programmed Cell Death 1 Receptor / Lung Neoplasms / Antineoplastic Agents Type of study: Clinical_trials / Systematic_reviews Limits: Humans Language: En Journal: Pharmacol Res Journal subject: FARMACOLOGIA Year: 2020 Type: Article Affiliation country: China